Advanced search
Start date
Betweenand

Discovering new drug leads against Chagas Disease Based on Brazilian bioactive plant molecules

Grant number: 19/13906-4
Support type:Regular Research Grants
Duration: December 01, 2019 - November 30, 2021
Field of knowledge:Physical Sciences and Mathematics - Chemistry - Organic Chemistry
Mobility Program: SPRINT - Projetos de pesquisa - Mobilidade
Principal Investigator:João Henrique Ghilardi Lago
Grantee:João Henrique Ghilardi Lago
Principal investigator abroad: David Sarlah
Institution abroad: University of Illinois at Urbana-Champaign, United States
Home Institution: Centro de Ciências Naturais e Humanas (CCNH). Universidade Federal do ABC (UFABC). Ministério da Educação (Brasil). Santo André , SP, Brazil
Assoc. researchers:André Gustavo Tempone Cardoso
Associated research grant:18/07885-1 - Biomolecules from plant species of remnant areas of the Atlantic Forest and Cerrado to treat neglected tropical diseases - chemical and pharmacological aspects, AP.BTA.R

Abstract

Natural products obtained from Brazilian flora constitute a powerful and diverse source of bioactive molecules, which are increasingly in high demand for the development of new human therapeutics. These bioactive molecules can be considered 'pre-optimized' by Nature to possess bioactivity and 'drug-like' properties. Affirmation of these statements is realized in the fact that more than 50% of the 1,355 new drugs registered between 1981 and 2016 were derived directly or in part from natural products. In this project, we aim to embrace the concept of "Brazilian Flora Drug Discovery (BFDD)", and apply it to the neglected disease American trypanosomiasis (Chagas disease). The project will encompass natural product isolation (Federal University of ABC), bioactivity guided screening (Adolfo Lutz Institute) and chemical synthesis and preparation of novel analogs (University of Illinois). This trident approach to BFDD will bridge the gap between molecular structure/bioactivity and novel drug scaffolds, thus expediting drug discovery for treating Chagas disease. (AU)